As of 2025-09-17, the Fair Value of Bioventus Inc (BVS) is -0.01 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.84 USD, the upside of Bioventus Inc is -100.14%.
With the market price of 6.84 USD and our fair value calculation, Bioventus Inc (BVS) is not a good investment. Investing in Bioventus stocks now will result in a potential loss of 100.14%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 16.40 | 19.40 | -158.70 | -156.23 | -33.54 | -62.53 |
| YoY growth | 137.68% | 18.29% | -918.04% | 1.56% | 78.53% | -136.40% |
| Market Cap (mil) | 565.53 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | -136.40% |
| TTM earnings | -0.16 |